Lingwen Cui

Title: Innovations of Lingwen Cui in Pharmaceutical Composition

Introduction

Lingwen Cui is a notable inventor based in Thousand Oaks, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of bispecific antibody constructs. His work focuses on improving the storage and administration of these innovative compositions.

Latest Patents

Lingwen Cui holds a patent for a pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration. The invention provides an enhanced pharmaceutical composition that includes a bispecific antibody construct, a preservative, and a diluent. This composition ensures that the bispecific antibody construct remains stable and recoverable, with a concentration range from about 0.5 μg/ml to 20 mg/ml.

Career Highlights

Lingwen Cui is associated with Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to contribute to groundbreaking advancements in the pharmaceutical industry. His expertise in antibody constructs has positioned him as a valuable asset in the field.

Collaborations

Lingwen Cui has collaborated with notable colleagues, including Jeff Abel and Devrishi Goswami. These collaborations have fostered an environment of innovation and have led to significant advancements in their respective projects.

Conclusion

Lingwen Cui's contributions to pharmaceutical compositions highlight his innovative spirit and dedication to improving medical treatments. His work continues to influence the field and pave the way for future advancements in biotechnology.